MarketScreener Strategies Vertex Pharmaceuticals Incorporated
Stocks
VRTX
US92532F1003
Pharmaceuticals
|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 491.34 USD | +2.32% |
|
489.96 | -0.28% |
| 06-24 | What if the market is signaling a clear pause in the AI rally for the summer? |  |
| 06-22 | Proteome contract win; Eco Buildings milestone | AN |
MarketScreener Strategies
Search
 | Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease | December 11, 2023 at 05:47 am |
 | Vertex Pharmaceuticals Incorporated : Confirms growth trajectory | May 04, 2023 at 09:35 am |
 | Vertex Pharmaceuticals : A very promising pipeline | January 11, 2023 at 05:20 am |
No results match your criteria
- Stock Market
- Stocks
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
